Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.92 USD | +0.19% | +6.69% | -23.41% |
Financials (USD)
Sales 2024 * | 132M | Sales 2025 * | 217M | Capitalization | 5.7B |
---|---|---|---|---|---|
Net income 2024 * | -623M | Net income 2025 * | -589M | EV / Sales 2024 * | 54.1 x |
Net Debt 2024 * | 1.42B | Net Debt 2025 * | 1.25B | EV / Sales 2025 * | 32.1 x |
P/E ratio 2024 * |
-9.31
x | P/E ratio 2025 * |
-9.84
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.06% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | +0.19% | ||
1 week | +6.69% | ||
Current month | -9.46% | ||
1 month | -12.38% | ||
3 months | -26.05% | ||
6 months | +13.97% | ||
Current year | -23.41% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 30.92 | +0.19% | 2,004,455 |
24-03-27 | 30.86 | +3.70% | 1,785,083 |
24-03-26 | 29.76 | +1.26% | 1,956,297 |
24-03-25 | 29.39 | -0.64% | 765,773 |
24-03-22 | 29.58 | +2.07% | 1,569,061 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.41% | 5.7B | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |